To investigate how miR-10a is downregulated in RA FLSs, the classical proinflammatory factors TNF-α and IL-1β, which have been employed clinically as therapeutic targets in RA treatment, were used to treat FLSs. Here, IL1B is linked to rheumatoid arthritis.